Concepedia

A Phase I–II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas

Ulrik Lassen, Lars Henrik Jensen, Morten Mau‐Sørensen, Kristoffer Staal Rohrberg, Z. Ujmajuridze, Anders Jakobsen

Acta Oncologica · 2010 · 19 citations · 26 references

DOIFull text

Open access

Abstract

This outpatient regimen was very feasible with significant activity and a favourable safety profile. Further studies will explore this combination with addition of newer targeted agents.

References

26

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.3K citations · Full text

Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document

Shahid A. Khan, Brian R Davidson, Robert Goldin et al. · Gut · 2002 · 643 citations · Full text

, , +15

Randomized Phase II Comparison of Dose-Intense Gemcitabine: Thirty-Minute Infusion and Fixed Dose Rate Infusion in Patients With Pancreatic Adenocarcinoma

Margaret A. Tempero, William Plunkett, Veronique Ruiz van Haperen et al. · Journal of Clinical Oncology · 2003 · 519 citations

Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials

Florian Eckel, Roland M. Schmid · British Journal of Cancer · 2007 · 462 citations · Full text

Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma

Daitaro Yoshikawa, Hidenori Ojima, Motoki Iwasaki et al. · British Journal of Cancer · 2007 · 407 citations · Full text